Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France

The field of gene therapy for bone and joint disorders has grown considerably over the last two and a half years. Investigators have shown that ex vivo or in vivo gene transfer is highly effective in blocking arthritis or facilitating repair of damaged cartilage or bone. The feasibility of applying...

Descripción completa

Detalles Bibliográficos
Autores principales: Robbins, Paul D, Jorgensen, Christian, Evans, Christopher H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128905/
http://dx.doi.org/10.1186/ar317
_version_ 1782120353820049408
author Robbins, Paul D
Jorgensen, Christian
Evans, Christopher H
author_facet Robbins, Paul D
Jorgensen, Christian
Evans, Christopher H
author_sort Robbins, Paul D
collection PubMed
description The field of gene therapy for bone and joint disorders has grown considerably over the last two and a half years. Investigators have shown that ex vivo or in vivo gene transfer is highly effective in blocking arthritis or facilitating repair of damaged cartilage or bone. The feasibility of applying gene therapy for the treatment of arthritis in humans has also been demonstrated. Thus, gene therapy appears poised to make significant contributions to the clinical treatment of joint and bone diseases in the near future.
format Text
id pubmed-128905
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1289052002-10-28 Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France Robbins, Paul D Jorgensen, Christian Evans, Christopher H Arthritis Res Meeting Report The field of gene therapy for bone and joint disorders has grown considerably over the last two and a half years. Investigators have shown that ex vivo or in vivo gene transfer is highly effective in blocking arthritis or facilitating repair of damaged cartilage or bone. The feasibility of applying gene therapy for the treatment of arthritis in humans has also been demonstrated. Thus, gene therapy appears poised to make significant contributions to the clinical treatment of joint and bone diseases in the near future. BioMed Central 2001 2001-07-31 /pmc/articles/PMC128905/ http://dx.doi.org/10.1186/ar317 Text en Copyright © 2001 BioMed Central Ltd
spellingShingle Meeting Report
Robbins, Paul D
Jorgensen, Christian
Evans, Christopher H
Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France
title Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France
title_full Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France
title_fullStr Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France
title_full_unstemmed Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France
title_short Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France
title_sort gene therapy moves forward - the second international meeting on gene and cell therapies of arthritis and related disorders, 17-18 may 2001, montpellier, france
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128905/
http://dx.doi.org/10.1186/ar317
work_keys_str_mv AT robbinspauld genetherapymovesforwardthesecondinternationalmeetingongeneandcelltherapiesofarthritisandrelateddisorders1718may2001montpellierfrance
AT jorgensenchristian genetherapymovesforwardthesecondinternationalmeetingongeneandcelltherapiesofarthritisandrelateddisorders1718may2001montpellierfrance
AT evanschristopherh genetherapymovesforwardthesecondinternationalmeetingongeneandcelltherapiesofarthritisandrelateddisorders1718may2001montpellierfrance

Ejemplares similares